Research Paper Volume 15, Issue 11 pp 4699—4713
Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma
Figure 5. Identification of LPCAT4 biological function in LIHC. (A) LPCAT4 mRNA expression level was examined by RT-PCR assay. (B) LPCAT4 protein expression level in LIHC tissues. (C) Western blot assay was used to examine LPCAT4 protein down-regulation efficiency. (D) MTT assay was used to analyze cell growth. (E) Colony formation ability in LPCAT4 down-regulation and control group.